JPH0229316B2 - - Google Patents
Info
- Publication number
- JPH0229316B2 JPH0229316B2 JP56189859A JP18985981A JPH0229316B2 JP H0229316 B2 JPH0229316 B2 JP H0229316B2 JP 56189859 A JP56189859 A JP 56189859A JP 18985981 A JP18985981 A JP 18985981A JP H0229316 B2 JPH0229316 B2 JP H0229316B2
- Authority
- JP
- Japan
- Prior art keywords
- interferon
- suspension
- cells
- acidifying
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000014150 Interferons Human genes 0.000 claims description 46
- 108010050904 Interferons Proteins 0.000 claims description 46
- 229940079322 interferon Drugs 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 33
- 210000004027 cell Anatomy 0.000 claims description 32
- 239000000725 suspension Substances 0.000 claims description 28
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 102000006992 Interferon-alpha Human genes 0.000 claims description 6
- 108010047761 Interferon-alpha Proteins 0.000 claims description 6
- 102000008070 Interferon-gamma Human genes 0.000 claims description 6
- 108010074328 Interferon-gamma Proteins 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 229940044627 gamma-interferon Drugs 0.000 claims description 6
- 230000003472 neutralizing effect Effects 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 description 18
- 229940047124 interferons Drugs 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000008188 pellet Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 108090000467 Interferon-beta Proteins 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 102000003996 Interferon-beta Human genes 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101710179738 6,7-dimethyl-8-ribityllumazine synthase 1 Proteins 0.000 description 1
- 101710179734 6,7-dimethyl-8-ribityllumazine synthase 2 Proteins 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 101710186608 Lipoyl synthase 1 Proteins 0.000 description 1
- 101710137584 Lipoyl synthase 1, chloroplastic Proteins 0.000 description 1
- 101710090391 Lipoyl synthase 1, mitochondrial Proteins 0.000 description 1
- 101710186609 Lipoyl synthase 2 Proteins 0.000 description 1
- 101710122908 Lipoyl synthase 2, chloroplastic Proteins 0.000 description 1
- 101710101072 Lipoyl synthase 2, mitochondrial Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21042680A | 1980-11-26 | 1980-11-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57118798A JPS57118798A (en) | 1982-07-23 |
| JPH0229316B2 true JPH0229316B2 (enrdf_load_stackoverflow) | 1990-06-28 |
Family
ID=22782860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56189859A Granted JPS57118798A (en) | 1980-11-26 | 1981-11-26 | Obtaining of interferon solution |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57118798A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3432196A1 (de) * | 1984-09-01 | 1986-03-06 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden |
-
1981
- 1981-11-26 JP JP56189859A patent/JPS57118798A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57118798A (en) | 1982-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4315852A (en) | Extraction of interferon from bacteria | |
| EP0102989B1 (en) | Process for recovering human ifn-beta from a transformed microorganism | |
| JP2633510B2 (ja) | 動物インターフェロン | |
| US4364863A (en) | Extraction of interferon from bacteria | |
| JP2004528005A (ja) | 生物学的に活性なタンパク質およびペプチドのファージ依存性超産生 | |
| JPH0229316B2 (enrdf_load_stackoverflow) | ||
| US4958007A (en) | Extraction of human interleukin-4- from bacteria | |
| EP1356076B1 (en) | Methods and compositions for extracting proteins from cells | |
| CN101392256A (zh) | 野猪α-干扰素的基因合成和载体构建及产物的生产方法 | |
| CN114403158B (zh) | 一种耐硼赖氨酸芽孢杆菌细菌素类似物及其在抑制丁香假单胞菌番茄致病变种中的应用 | |
| CN112812165B (zh) | 一种水虻抗菌肽Hidefensin1及应用 | |
| NO820943L (no) | Fremgangsmaate ved gjenvinning av produkter produsert av vertsorganismer. | |
| RU2231545C1 (ru) | Штамм дрожжей pichia pastoris ps105(pbig)-продуцент внутриклеточного иммунного интерферона быка, рекомбинантная плазмидная днк pbig, обеспечивающая биосинтез внутриклеточного иммунного интерферона быка и способ конструирования рекомбинантной плазмидной днк pbig | |
| US5136024A (en) | Extraction of granulocyte macrophage colony stimulating factor from bacteria | |
| JP2831473B2 (ja) | 細菌からの異種の不溶性タンパク質の抽出 | |
| CN105732792A (zh) | 一种酵母表达的鸡Cathelicidin1抗菌肽及其制备方法与应用 | |
| RU2180687C1 (ru) | Штамм дрожжей pichia pastoris - продуцент фибробластного интерферона человека, рекомбинантная плазмидная днк phif и способ ее конструирования | |
| JPS5982093A (ja) | インタ−フエロンの効率的生産法 | |
| CN114209811B (zh) | 一种耐硼赖氨酸芽孢杆菌细菌素类似物的制备方法及其在抑制短小芽孢杆菌中的应用 | |
| Rauenbusch et al. | Isolation and crystallisation of L-asparaginase from E. coli | |
| RU1770359C (ru) | Рекомбинантна плазмидна ДНК pJDB (MSIL), обеспечивающа синтез интерлейкина-2 человека в клетках дрожжей SасснаRомUсеS ceReUISIaL, способ ее получени и штамм дрожжей SасснаRомYсеS ceReUISIaL - продуцент интерлейкина-2 человека | |
| WO1999024067A1 (en) | Micobacterium vaccae preparation comprising cold-shock proteins and its use in therapy | |
| JPS5982094A (ja) | インタ−フエロンの効率的生産方法 |